logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
delete
arrow
返回
H

Hussain Abdulrahman Al‐Omar

clinical pharmacy

13H指数
75论文数
514被引数
收录论文 29
发表时间
logo
Mapping the landscape of managed entry agreements: a systematic review of global frameworks; system-level components; and implementation challenges规划管理进入协议的前景: 对全球框架的系统审查; 系统级组件; 和实施挑战
errFrontiers in Pharmacology
IF4.8
err2026-04-20
err0
errOAAI
errHA Hussain Abdulrahman Al-Omar †; AA Asma Abdulaziz Almuhsin †; LH Lolwa Hamad Almudaiyan †; AH Amal Hassan Al-Najjar †; LC Laila Carolina Abu Esba †; HA Hind Almodaimegh †; JA Jehan Alamre †; CC Consuela Cheriece Yousef †; MA Mansoor Ahmed Khan †; KA Khalid AlYahya †; ES Esraa S. Altawil †; AS Abdualmajeed Saad Binjumayah; FA Faisal Awwadh Alharbi; ST Sultan Tawfiq AlShurbaji †; FM Fatma Maraiki †; JE Jaime Espín †; RT Rosanna Tarricone †; PK Panos Kanavos †
err分享
err收藏
Expert Delphi consensus on surrogate endpoints for treatment assessment in metabolic dysfunction-associated steatohepatitis代谢功能障碍相关脂肪性肝炎治疗评估的替代终点专家德尔菲共识
errClinical Gastroenterology and Hepatology
IF12
err2025-12-06
err0
PREAI
errArun J. Sanyal; Atsushi Nakajima; Elisabetta Bugianesi; Giada Sebastiani; Jörn M. Schattenberg; Leon A. Adams; Mazen Noureddin; Masato Yoneda; Pierre Bedossa; Zobair M. Younossi; Assim A. Alfadda; Andreas Geier; Frank Tacke; Giulio Marchesini; Giovanni Targher; Hussain Abdulrahman Al-Omar; Hannes Hagström; Juan G. Abraldes; Jerome Boursier; Kento Imajo
err分享
err收藏
Navigating barriers to real-world evidence utilization for drug regulatory affairs and market access in Saudi Arabia导航沙特阿拉伯药物监管事务和市场准入中现实世界证据利用的障碍
errFrontiers in Pharmacology
IF4.8
err2025-12-02
err0
errOAAI
errHatouf H. Sukkarieh†; Nourah Al Fayez†; Hussain Abdulrahman Al-Omar†; Nura O. Azmi; Bushra Syed; Raed A. Albar; Nawaf Al Bali
err分享
err收藏
Cost of Metabolic Dysfunction-Associated Steatotic Liver Disease Screening Among All People Living With Diabetes in Six Countries六国中所有糖尿病患者代谢功能障碍相关脂肪性肝病筛查的成本
errLiver International
IF5.2
err2025-11-05
err0
errOAAI
errJeffrey V. Lazarus; Leire Agirre-Garrido; J. Emilio Miralles-Sanchez; Melina I. Manolas; Frank Tacke; Cristiane A. Villela-Nogueira; Hussain Abdulrahman Al-Omar; Saleh A. Alqahtani; Lamya Mohammed Yahya Alzubaidi; Meena Bansal; Kenneth Cusi; Scott D. Isaacs; Didac Mauricio; Teruki Miyake; Rodrigo O. Moreira; Shoko Nakazawa; Silvana Pannain; Juan M. Pericàs; Michael Roden; Hirokazu Takahashi; Nicolai Brachowicz
err分享
err收藏
Featured Cover精选封面
errLiver International
IF5.2
err2025-10-30
err0
errOAAI
errJeffrey V. Lazarus; Leire Agirre-Garrido; J. Emilio Miralles-Sanchez; Melina I. Manolas; Frank Tacke; Cristiane A. Villela-Nogueira; Hussain Abdulrahman Al-Omar; Saleh A. Alqahtani; Lamya Mohammed Yahya Alzubaidi; Meena Bansal; Kenneth Cusi; Scott D. Isaacs; Didac Mauricio; Teruki Miyake; Rodrigo O. Moreira; Shoko Nakazawa; Silvana Pannain; Juan M. Pericàs; Michael Roden; Hirokazu Takahashi; Nicolai Brachowicz
err分享
err收藏
Challenges in evaluation and reimbursement of drugs for rare diseases in Saudi Arabia: a Delphi expert consensus沙特阿拉伯罕见病药物评估与报销的挑战：一项德尔菲专家共识
errJournal of Pharmaceutical Policy and Practice
IF2.5
err2025-10-28
err0
errOAAI
errLaila Carolina Abu Esba; Consuela Cheriece Yousef; Mansoor Ahmed Khan; Sakra Balhareth; Hussain A. Al-Omar; Amal Al-Najjar; Aljawharah Alkoraishi; Abdullah M. Alhammad; Ziyad Saeed Almalki; Esraa S. Altawil; Roaa Al Gain; Mohamed Ahmed; Hend Metwali; Layla Al Anizy; Fatma Maraiki; Abdulrazaq Al Jazairi; Abdulaziz Alhossan; Mohammed Al Harbi; Hind Almodaimegh
err分享
err收藏
Supplementary Material for Projected Global Clinical, Humanistic, and Economic Impact of Metabolic Dysfunction-Associated Steatohepatitis (MASH): The Cost of Inaction Based on Data from Nine Countries代谢功能障碍相关脂肪性肝炎（MASH）的全球临床、人文和经济影响预测项目补充资料：基于九国数据的无所作为的成本
errClinical Gastroenterology and Hepatology
IF12
err2025-09-08
err0
PREAI
errZobair M. Younossi; James M. Paik; Jeffrey V. Lazarus; Patrizia Burra; Yuichiro Eguchi; Frank Tacke; Javier Crespo; Cristiane A. Villela-Nogueira; Paul N. Brennan; Hussain Abdulrahman Al-Omar; Manuel Romero-Gomez; Cyrielle Caussy; Mário Guimarães Pessoa; Kenneth Cusi; Michael Roden; Hirokazu Takahashi; Amalia Gastaldelli; Jörn M. Schattenberg; Claudia Pinto Oliveira; Takumi Kawaguchi; Yuko Eguchi; Jerome Boursier; Faisal Abaalkhail; Jeremy W. Tomlinson; Alina M. Allen; Vincent Wai-Sun Wong; Elisabetta Bugianesi; Philip N. Newsome; Jose Luis Calleja; Nicolai Brachowicz; Leire Agirre-Garrido; Douglas Maya-Miles; Habeeb I.A. Razack; Henry E. Mark; Ariana Nader; Sara Battistella; Jennifer Margier; Alessandra Risso; Maria Stepanova; Fatema Nader; Linda Henry; Laurent Castera; Saleh A. Alqahtani
err分享
err收藏
Contextual factors in value-based decision support to enhance health technologies adoption: the case of biosimilars基于价值决策支持中的情境因素以促进健康技术采纳：生物类似药案例
errFrontiers in Pharmacology
IF4.8
err2025-08-13
err0
errOAAI
errMaximilian Otte; Zoltán Kaló; Hussain Abdulrahman Al-Omar†; Meindert Boysen; Yingyao Chen; Ana Paula Beck Da Silva Etges; Guvenc Kockaya; Iñaki Gutierrez-Ibarluzea; Ahmed Mohammed Seyam; Deirdre Mullen; Hans-Peter Dauben
err分享
err收藏
A strategic framework for synergizing managed entry agreement efforts to access pharmaceutical products in Saudi Arabia-results from a multi-stakeholder workshop一个战略框架，用于协同沙特阿拉伯获取药品的准入协议努力——多利益相关方研讨会的结果
errJOURNAL OF MEDICAL ECONOMICS
IF3
err2025-05-21
err0
errOAAI
errHussain Abdulrahman Al-Omar; Asma Abdulaziz Almuhsin; Lolwa Hamad Almudaiyan; Amal Hassan Al-Najjar; Laila Carolina Abu Esba; Hind Almodaimegh; Esraa S. Altawil; Consuela Cheriece Yousef; Mansoor Ahmed Khan; Khalid AlYahya; Jehan Alamre; Fatma Maraiki; Jaime Espín; Rosanna Tarricone; Panos Kanavos
err分享
err收藏
Towards a sustainable rare disease and orphan drug ecosystem in Saudi Arabia: policy insights from a multi-stakeholder workshop迈向沙特阿拉伯可持续的罕见病与孤儿药生态系统：多利益相关方研讨会的政策洞见
errFRONTIERS IN PHARMACOLOGY
IF4.8
err2025-05-01
err0
errOAAI
errAbozaid, Ghada Mohammed; Al-Omar, Hussain Abdulrahman; Alrabiah, Abdulaziz; Almuaither, Asma; Mcknight, Amy Jayne
err分享
err收藏
A systematic review of obesity burden in Saudi Arabia: Prevalence and associated co-morbidities沙特阿拉伯肥胖负担的系统评价: 患病率和相关合并症
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2024-11-01
err2
errOAAI
errAl-Omar, Hussain A.; Alshehri, Ali; Alqahtani, Saleh A.; Alabdulkarim, Hana; Alrumaih, Ali; Eldin, Mahmoud S.
err分享
err收藏
Cost saving analysis of prediabetes intervention modalities in comparison with inaction using Markov state transition model-A multiregional case study
errJOURNAL OF DIABETES
IF3.7
err2024-04-25
err0
errOAAI
errAl-Omar, Hussain Abdulrahman; Czech, Marcin; Nam, Tran Quang; Gottwald-Hostalek, Ulrike; Vesic, Nikola; Whitehouse, James; Dawson, Maddy
err分享
err收藏
Pharmacy practice in hospital settings in GCC countries: Dispensing and administration
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2023-03-01
err4
errOAAI
errMayet, Ahmed Y.; Khurshid, Fowad; Al-Omar, Hussain A.; Alghanem, Sarah S.; Alsultan, Mohammed S.; Al-jedai, Ahmed H.
err分享
err收藏
The Impact of Obesity in Saudi Arabia: Healthcare Resource Use and Costs Associated with Obesity-Related Complications沙特阿拉伯肥胖的影响: 与肥胖相关并发症相关的医疗资源使用和成本
errADVANCES IN THERAPY
IF4
err2023-01-21
err9
errOAAI
errAl-Omar, Hussain A.; Alshehri, Ali; Abanumay, Abdulmohsen; Alabdulkarim, Hana; Alrumaih, Ali; Eldin, Mahmoud S.; Alqahtani, Saleh A.
err分享
err收藏
Obesity Burden and Impact of Weight Loss in Saudi Arabia: A Modelling Study
errADVANCES IN THERAPY
IF4
err2023-01-12
err15
errOAAI
errAlqahtani, Saleh A.; Al-Omar, Hussain A.; Alshehri, Ali; Abanumay, Abdulmohsen; Alabdulkarim, Hana; Alrumaih, Ali; Eldin, Mahmoud S.; Schnecke, Volker
err分享
err收藏
Pharmacy practice in hospital settings in GCC countries: Prescribing and transcribing
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2021-09-01
err1
errOAAI
errAl-Jedai, Ahmed H.; Khurshid, Fowad; Mayet, Ahmed Y.; Al-Omar, Hussain A.; Alghanem, Sarah S.; Alsultan, Mohammed S.
err分享
err收藏
Value drivers for pharmaceutical products in health technology assessment (HTA) in Saudi Arabia: Results from a capacity Building, Multi-Stakeholder workshop
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2021-09-01
err5
errOAAI
errAl-Omar, Hussain A.; Aljuffali, Ibrahim A.; Sola-Morales, Oriol
err分享
err收藏
Exploring Physicians' Views, Perceptions and Experiences about Broad-Spectrum Antimicrobial Prescribing in a Tertiary Care Hospital Riyadh, Saudi Arabia: A Qualitative Approach
errANTIBIOTICS-BASEL
IF4.6
err2021-03-31
err4
errOAAI
errAlsaleh, Nada A.; Al-Omar, Hussain A.; Mayet, Ahmed Y.; Mullen, Alexander B.
err分享
err收藏
Evaluating the appropriateness of carbapenem and piperacillin-tazobactam prescribing in a tertiary care hospital in Saudi Arabia
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2020-11-01
err9
errOAAI
errAlsaleh, Nada A.; Al-Omar, Hussain A.; Mayet, Ahmed Y.; Mullen, Alexander B.
err分享
err收藏
Pharmaceutical companies views on a health technology assessment (HTA) entity in Saudi Arabia
errSAUDI PHARMACEUTICAL JOURNAL
IF3.4
err2020-06-01
err11
errOAAI
errAl-Omar, Hussain Abdulrahman; Attuwaijri, Abdulaziz Abdulhadi; Aljuffali, Ibrahim Abdulrahman
err分享
err收藏

研究方向

暂时未获取到该数据
合作学者
合作期刊
A
Arun J. Sanyal
H 指数: 166 · 论文数: 1.4K
V
Vincent Wai‐Sun Wong
H 指数: 142 · 论文数: 1.2K
Z
Zobair M. Younossi
H 指数: 140 · 论文数: 1.5K
A
Azeem Majeed
H 指数: 129 · 论文数: 1.3K
F
Frank Tacke
H 指数: 124 · 论文数: 1.4K
查看更多